Tauriga Sciences ( OTCMKTS:TAUG ) and Nutra Pharma ( OTCMKTS:NPHC ) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, dividends and profitability.
Risk & Volatility
Tauriga Sciences has a beta of 2, meaning that its share price is 100% more volatile than the S&P 500. Comparatively, Nutra Pharma has a beta of 6.11, meaning that its share price is 511% more volatile than the S&P 500.
Insider and Institutional Ownership
0.0% of Nutra Pharma shares are owned by institutional investors. 6.2% of Tauriga Sciences shares are owned by company insiders. Comparatively, 61.5% of Nutra Pharma shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
This table compares Tauriga Sciences and Nutra Pharma’s net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Tauriga Sciences N/A -261.04% -117.86% Nutra Pharma -4,741.67% N/A -1,740.23% Earnings & Valuation
This table compares Tauriga Sciences and Nutra Pharma’s gross revenue, earnings per share and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Tauriga Sciences N/A N/A -$30,000.00 N/A N/A Nutra Pharma $120,000.00 6.67 -$4.02 million N/A N/A Tauriga Sciences has higher earnings, but lower revenue than Nutra Pharma.
This is a breakdown of recent ratings and price targets for Tauriga Sciences and Nutra Pharma, as provided by MarketBeat.com. Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tauriga Sciences 0 0 0 0 N/A Summary
Nutra Pharma beats Tauriga Sciences on 5 of the 8 factors compared between the two stocks.
About Tauriga Sciences
Tauriga Sciences, Inc. produces, licenses, and sells lip balm products under the HerMan brand name. The company was founded in 2001 and is based in New York, New York.
About Nutra Pharma Nutra Pharma logo Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases primarily in the United States. The company offers Nyloxin and Nyloxin Extra Strength products, which are used as an oral spray for treating back pain, neck pain, headaches, joint pain, migraines, and neuralgia, as well as a topical gel for treating joint pain, neck pain, arthritis pain, and pain associated with repetitive stress; Pet Pain-Away, an over-the-counter pain reliever to treat pain in cats and dogs; Luxury Feet, an over-the-counter pain reliever to treat foot pain from high heels and stilettos; Nyloxin Military Strength for treating pain to the United States Military and Veteran’s Administration; and Equine Nyloxin, a topical therapy for chronic pain in horses. It is also developing RPI-78M to treat neurological diseases and autoimmune diseases, including multiple sclerosis, adrenomyeloneuropathy, amyotrophic lateral sclerosis, rheumatoid arthritis, and myasthenia gravis; RPI-MN to treat viral diseases, including human immunodeficiency virus/AIDS and herpes; RPI-78 for pain and arthritis; and RPI-70 for pain. The company has a collaboration agreement with the International Security Group to develop nerve agent counter measures. Nutra Pharma Corp. was founded in 2000 and is based in Coral Springs, Florida.
Receive News & Ratings for Tauriga Sciences Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Tauriga Sciences and related companies with MarketBeat.com’s FREE daily email newsletter .
Click here to view original web page at Tauriga Sciences (TAUG) & Nutra Pharma (NPHC) Financial Contrast